Fortis Healthcare Shares Jump 6.62% After SEBI Clears IHH’s Long-Pending Open Offer

Mumbai, October 6, 2025: Fortis Healthcare Limited’s share price is witnessing strong trading activity following SEBI’s approval for Malaysia-based IHH Healthcare Berhad to proceed with its long-delayed open offer for Fortis Healthcare and its subsidiary, Fortis Malar Hospitals Ltd.

As of 6 October 2025, at 12:32 pm IST, Fortis Healthcare Ltd (NSE: FORTIS) was trading at ₹1,045.35, up ₹64.95 (6.62%). The stock opened at ₹994.00, with an intraday high of ₹1,055.40 and a low of ₹987.10 during this session. Fortis Healthcare’s market capitalization stands at ₹78.96K Cr, with a P/E ratio of 90.86 and a dividend yield of 0.096%. The stock’s 52-week high and low are ₹1,055.40 and ₹572.00, respectively, with a quarterly dividend amount of ₹0.251.

Fortis Healthcare Limited is an Indian company that operates the largest chain of multi-speciality hospitals in India. It was established in 1996 and is headquartered in Mumbai, Maharashtra. The company is part of Nifty Midcap 50, and has FORTIS as its NSE ticker symbol and 532843 as the BSE code.

SEBI Clears IHH’s Long-Pending Open Offer

The significant rally in the share price comes after the company announced that the Securities and Exchange Board of India (SEBI) has cleared Malaysia-based IHH Healthcare Berhad to proceed with its long-delayed open offer for Fortis Healthcare and its subsidiary, Fortis Malar Hospitals Ltd. This comes after the open offer by IIH Healthcare has been pending since 2018.

According to IHH’s filing on the Bursa Malaysia, the approval allows the group to acquire up to 197,025,660 equity shares through the Fortis Open Offer, and acquire up to 4,894,308 shares of Fortis Malar Hospitals Limited through the Malar Open Offer. The acquisition represents 26.10% of Fortis’ expanded voting share capital. IHH had earlier subscribed to 235,294,117 new shares of Fortis Healthcare via preferential allotment through its subsidiary Northern TK Venture Pte Ltd, an indirect wholly-owned unit of IHH Healthcare Berhad.

Resolution of Long-Standing Dispute

SEBI’s approval resolves a long-standing dispute that had prevented IIH from investing in Fortis Healthcare and its subsidiary. With the transaction completed, IIH can expand its presence in India and potentially boost its sales.

REF: https://nsearchives.nseindia.com/corporate/FORTIS_03102025180942_Finalintimation.pdf

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations